Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyasu Ohtaka

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Progress in Biophysics and Molecular Biology|December 2, 2004
Adaptive inhibitors of the HIV-1 proteaseHiroyasu Ohtaka, Ernesto Freire
Biochemistry|November 19, 2003
Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutationsHiroyasu Ohtaka, Arne Schön, Ernesto Freire
Protein Science : a Publication of the Protein Society|July 27, 2002
Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 proteaseHiroyasu Ohtaka, Adrian Velázquez-Campoy, Dong Xie, et al.
The Journal of Physical Chemistry. A|February 27, 2015
Diffusion-facilitated direct determination of intrinsic parameters for rapid photoinduced bimolecular electron-transfer reactions in nonpolar solventsAndrew D Scully, Hiroyasu Ohtaka, Makoto Takezaki, et al.
Current Protocols in Cell Biology|January 30, 2008
Isothermal titration calorimetryAdrián Velázquez-Campoy, Hiroyasu Ohtaka, Azin Nezami, et al.
The International Journal of Biochemistry & Cell Biology|June 9, 2004
Thermodynamic rules for the design of high affinity HIV-1 protease inhibitors with adaptability to mutations and high selectivity towards unwanted targetsHiroyasu Ohtaka, Salman Muzammil, Arne Schön, et al.
Current Drug Targets. Infectious Disorders|February 3, 2004
Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor designAdrian Velazquez-Campoy, Salman Muzammil, Hiroyasu Ohtaka, et al.
Chemical Biology & Drug Design|June 22, 2007
Compensating enthalpic and entropic changes hinder binding affinity optimizationVirginie Lafont, Anthony A Armstrong, Hiroyasu Ohtaka, et al.
The Journal of Physical Chemistry. A|May 30, 2008
Effect of diffusion on the photoinduced reaction between a tetra-anionic porphyrin and methylviologen cation in methanolSanjay Pant, Hiroyasu Ohtaka-Saiki, Makoto Takezaki, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2013
4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitorSeisuke Mimori, Hiroyasu Ohtaka, Yukari Koshikawa, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Progress in Biophysics and Molecular Biology|December 2, 2004
Adaptive inhibitors of the HIV-1 proteaseHiroyasu Ohtaka, Ernesto Freire
Biochemistry|November 19, 2003
Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutationsHiroyasu Ohtaka, Arne Schön, Ernesto Freire
Protein Science : a Publication of the Protein Society|July 27, 2002
Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 proteaseHiroyasu Ohtaka, Adrian Velázquez-Campoy, Dong Xie, et al.
The Journal of Physical Chemistry. A|February 27, 2015
Diffusion-facilitated direct determination of intrinsic parameters for rapid photoinduced bimolecular electron-transfer reactions in nonpolar solventsAndrew D Scully, Hiroyasu Ohtaka, Makoto Takezaki, et al.
Current Protocols in Cell Biology|January 30, 2008
Isothermal titration calorimetryAdrián Velázquez-Campoy, Hiroyasu Ohtaka, Azin Nezami, et al.
The International Journal of Biochemistry & Cell Biology|June 9, 2004
Thermodynamic rules for the design of high affinity HIV-1 protease inhibitors with adaptability to mutations and high selectivity towards unwanted targetsHiroyasu Ohtaka, Salman Muzammil, Arne Schön, et al.
Current Drug Targets. Infectious Disorders|February 3, 2004
Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor designAdrian Velazquez-Campoy, Salman Muzammil, Hiroyasu Ohtaka, et al.
Chemical Biology & Drug Design|June 22, 2007
Compensating enthalpic and entropic changes hinder binding affinity optimizationVirginie Lafont, Anthony A Armstrong, Hiroyasu Ohtaka, et al.
The Journal of Physical Chemistry. A|May 30, 2008
Effect of diffusion on the photoinduced reaction between a tetra-anionic porphyrin and methylviologen cation in methanolSanjay Pant, Hiroyasu Ohtaka-Saiki, Makoto Takezaki, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2013
4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitorSeisuke Mimori, Hiroyasu Ohtaka, Yukari Koshikawa, et al.
Pageof 2